Boston Scientific Launches Cutting-Edge AFib Solution with Farapulse System

Boston Scientific has received FDA approval for its Farawave Nav catheter, an innovative tool that combines cardiac mapping and pulsed field ablation (PFA) to treat atrial fibrillation (AFib). Paired with new Faraview software, this catheter offers dynamic visualization of procedures and enhances ablation precision. Boston Scientific’s Farapulse system is the first to integrate PFA with mapping technology, positioning the company ahead of competitors. With PFA offering a safer alternative to traditional ablation methods, the Farapulse system provides physicians with an all-in-one solution for treating irregular heart rhythms.